Efficacy of Pembrolizumab Monotherapy in Japanese Patients with Advanced Gastric or Gastroesophageal Junction Cancer

ConclusionsThe current analysis provides valuable information that anti –PD-1 therapies are worthy of further assessment for gastric cancer.Trial RegistrationClinicalTrials.gov: NCT02335411 (KEYNOTE-059), NCT02370498 (KEYNOTE-061), and NCT02494583 (KEYNOTE-062).
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research